TIG Advisors LLC Has $24.36 Million Stock Holdings in Walgreens Boots Alliance, Inc. $WBA

Key Points

• TIG Advisors LLC increased its holdings in Walgreens Boots Alliance by an impressive 2,729.3%, acquiring over 2 million shares, which now represent 1.5% of its portfolio.
• Despite a net margin of -4.07%, Walgreens Boots Alliance reported a 7.2% year-over-year revenue growth for the quarter, with earnings per share exceeding analysts' expectations.
• The stock currently holds an average rating of "Reduce" from analysts, with a consensus price target of $10.15, reflecting cautious sentiment regarding its performance.

TIG Advisors LLC increased its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 2,729.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,181,026 shares of the pharmacy operator's stock after acquiring an additional 2,103,940 shares during the quarter. Walgreens Boots Alliance accounts for about 1.5% of TIG Advisors LLC's holdings, making the stock its 21st largest position. TIG Advisors LLC owned approximately 0.25% of Walgreens Boots Alliance worth $24,362,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in WBA. Marshall Wace LLP acquired a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth approximately $198,000. First Trust Advisors LP purchased a new stake in Walgreens Boots Alliance in the 4th quarter worth approximately $368,000. Dimensional Fund Advisors LP lifted its position in Walgreens Boots Alliance by 17.6% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,823,924 shares of the pharmacy operator's stock worth $17,016,000 after buying an additional 272,895 shares in the last quarter. Northern Trust Corp lifted its position in Walgreens Boots Alliance by 18.8% in the 4th quarter. Northern Trust Corp now owns 8,896,742 shares of the pharmacy operator's stock worth $83,007,000 after buying an additional 1,407,973 shares in the last quarter. Finally, Mercer Global Advisors Inc. ADV lifted its position in Walgreens Boots Alliance by 67.8% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 112,248 shares of the pharmacy operator's stock worth $1,021,000 after buying an additional 45,367 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company's stock.

Analyst Ratings Changes

A number of research firms have issued reports on WBA. Morgan Stanley reiterated an "underweight" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. UBS Group reiterated a "neutral" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. Finally, Wall Street Zen assumed coverage on shares of Walgreens Boots Alliance in a research report on Wednesday, May 21st. They set a "hold" rating on the stock. One research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat, Walgreens Boots Alliance presently has a consensus rating of "Reduce" and an average target price of $10.15.

Walgreens Boots Alliance Price Performance

WBA stock remained flat at $11.98 on Friday. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $13.25. The firm has a 50 day moving average of $11.74 and a 200 day moving average of $11.31. The company has a market cap of $10.37 billion, a price-to-earnings ratio of -1.64, a PEG ratio of 1.42 and a beta of 0.80. The company has a current ratio of 0.60, a quick ratio of 0.32 and a debt-to-equity ratio of 0.96.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.34 by $0.04. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The business had revenue of $38.99 billion for the quarter, compared to analyst estimates of $36.72 billion. During the same quarter in the previous year, the firm posted $0.63 earnings per share. Walgreens Boots Alliance's revenue was up 7.2% compared to the same quarter last year. As a group, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.